[18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients.

Elin PauwelsFrederik CleerenTérence TshibanguMichel KooleKim SerdonsJeroen DekervelEric Van CutsemChris VerslypeKoen Van LaereGuy BormansChristophe M Deroose

Published in: European journal of nuclear medicine and molecular imaging (2020)

Clinicaltrials.gov : NCT03883776, EudraCT: 2018-002827-40.

Keyphrases

pet imaging
pet ct
end stage renal disease
positron emission tomography
ejection fraction
newly diagnosed
chronic kidney disease
neuroendocrine tumors
peritoneal dialysis
patient reported
monte carlo